See a short video explaining how trace amine–associated receptor 1 (TAAR1) affects neurotransmitters in the brain.
This video is a publicly available educational resource provided by Sunovion Pharmaceuticals Inc. It was produced prior to and independent of the JCP InfoPack “Emerging Treatments in Schizophrenia.”
The Journal of Clinical Psychiatry
Insights February 17, 2022
TAAR1 Educational Resource Video
Vol 87 • 2026 • Number 1
Read the Current Issue
Original Research
Innovation in Psychiatric Drug Development: A Quantitative Analysis of FDA-Approved Psychiatric Drugs, 2012–2024
Meta-Analysis
Effectiveness of Peer-Administered Interventions for Perinatal Depression or Anxiety
Original Research
Effect of Adjuvant Metformin on Adherence to and Persistence of Treatment With SGAs in Nondiabetic Patients
Editorial
Thank You to the JCP Community
Editorial
Psychotherapy: Integral to Clinical Psychiatry
Original Research
Trends in Benzodiazepine Prescribing to Adults in the United States
Related Articles
Insights
Cognitive Impairment, Reward Pathways and Treatment Challenges in Schizophrenia Video
January 14, 2023
Evaluating different domains of negative symptoms separately to better understand their impact on functional outcomes, particularly cognitive symptoms, is important in the treatment of patients with schizophrenia, especially intervening...
Insights
Sequencing Therapy in the Treatment of Schizophrenia Video
January 14, 2023
Balancing and optimizing safety and efficacy when treating patients with schizophrenia can be challenging. New approaches to treatment may impact symptoms more effectively and contribute to better adherence. Sequencing,...
